arrow
M

Martin Höglund

Uppsala University
H指数:50
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia

急性髓系白血病的染色质景观和表观遗传异质性

Nature
IF48.5
2026-07-080
OAAI
A human pan-disease blood atlas of the circulating proteome

循环蛋白质组的人类泛疾病血液图谱

SCIENCE
IF45.8
2025-12-183
PRE
Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition

III期随机COMMODORE 2试验:Crovalimab在未接受补体抑制治疗的阵发性夜间血红蛋白尿(PNH)患者中的2年疗效与安全性

BLOOD
IF23.1
2024-11-050
PRE
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
2024-06-175
OAAI
Next generation pan-cancer blood proteome profiling using proximity extension assay
2023-07-1811
OAAI
Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children
LEUKEMIA
IF13.4
2022-12-2613
OAAI
Noninvasive detection of any-stage cancer using free glycosaminoglycans

使用游离糖胺聚糖无创检测任何阶段的癌症

2022-12-0535
OAAI
IFN-a with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
2022-09-018
OAAI
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial
2022-08-186
OA
A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias
2022-03-2414
OAAI
Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

转录组分析揭示与急性髓系白血病进展相关的促炎特征

2022-01-0718
OAAI
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial

来那度胺在新诊断的年轻和中年AML患者的强化治疗中的补充: HOVON-SAKK-132试验

2021-02-2241
OA
Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets
2021-02-0937
OA